NCT00186043View on ClinicalTrials.gov

Seroquel in the Treatment of Dysphoric Hypomania in Bipolar II

PHASE4CompletedINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions

Bipolar II Disorder

Interventions

DRUG

Quetiapine/Seroquel

Quetiapine/Seroquel

DRUG

Placebo

Placebo

Trial Locations (1)

94305

Terence Ketter, Stanford

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Stanford University

OTHER